Marshall Wace’s Harte-Hanks HHS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-49,889
Closed -$273K 2406
2023
Q2
$273K Sell
49,889
-21,222
-30% -$144K ﹤0.01% 2166
2023
Q1
$669K Buy
71,111
+10,490
+17% +$116K ﹤0.01% 1983
2022
Q4
$709K Sell
60,621
-9,431
-13% -$104K ﹤0.01% 2226
2022
Q3
$781K Buy
+70,052
New +$934K ﹤0.01% 2528

Other funds holding HHS

Marshall Wace's HHS Position: Q3 2023 in Review

Marshall Wace sold out of Harte-Hanks (HHS) in Q3 2023, closing a stake of 49,889 shares — an estimated $273K sold.

Marshall Wace first reported a position in HHS in Q3 2022 and held it in 4 quarters. The position peaked at $781K in Q3 2022. 23 funds tracked by Wall St. Rank hold HHS as of Q3 2023.

  • Marshall Wace reported no remaining Harte-Hanks position as of Q3 2023 after selling out during the quarter.
  • Marshall Wace sold 49,889 Harte-Hanks shares in Q3 2023, an estimated $273K.
  • Marshall Wace first reported a position in Harte-Hanks in Q3 2022 and held it in 4 quarters.
  • Marshall Wace's Harte-Hanks position peaked at $781K in Q3 2022.
  • 23 funds tracked by Wall St. Rank held Harte-Hanks as of Q3 2023.

Based on Marshall Wace's 13F filing for Q3 2023, filed 14 Nov 2023.